PRAME expression in hairy cell leukemia

Area of Science:

• Oncology
• Hematology
• Molecular Biology

Background:

• PRAME (Preferentially expressed antigen in melanoma) is a potential tumor marker.
• Previous studies suggest PRAME expression in Chronic Lymphocytic Leukemia (CLL).

Purpose of the Study:

• To investigate PRAME expression in B-cell malignancies, specifically CLL and Hairy Cell Leukemia (HCL).
• To evaluate the diagnostic and prognostic utility of PRAME in these hematological cancers.

Main Methods:

• Conventional Polymerase Chain Reaction (PCR) was used to detect PRAME expression.
• Real-time quantitative (TaqMan) PCR was employed for precise quantification of PRAME levels.
• Analysis included patients with HCL and CLL, as well as healthy donors.

Main Results:

• Conventional PCR detected PRAME in only 8% of HCL and 27% of CLL patients.
• Real-time quantitative PCR revealed PRAME expression in nearly all patients and normal donors.
• Significant PRAME overexpression was observed in both HCL and CLL compared to normal controls, but basal expression was widespread.

Conclusions:

• Hairy Cell Leukemia and Chronic Lymphocytic Leukemia exhibit distinct patterns of PRAME overexpression.
• The widespread basal expression of PRAME in normal B-cells may limit its utility as a biomarker for monitoring minimal residual disease in CLL and HCL.